Skip to main navigation
Harvard Bioscience Logo
  • About Us
    • Overview
    • History
    • Global Sites
    • Leadership Team
    • Our Vision
    • Careers
    • Contact Us
    • Code of Conduct
    • Privacy Policy
  • Our Global Brands
  • Investor Relations
    • Investor Overview
    • Corporate Governance
      • Leadership Team
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financials & Filings
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
    • Analyst Coverage
    • Investor FAQs
    • Contact Us
    • HART Spin-off
  • News + Events
    • Press Releases
    • Events & Presentations
  • Contact Us
  • Careers
Investor Relations
harvardbio-IR_03.jpg

Investor Relations

  • Investor Overview
  • Corporate Governance
    • Leadership Team
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials & Filings
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
  • Analyst Coverage
  • Investor FAQs
  • Contact Us
  • HART Spin-off

4

Symbol:

Open
High | Low
Volume

Copyright West LLC. Minimum 15 minutes delayed.

contact

Contact Us

Current Investor Presentation 3.4 MB
2017 Annual Report 2.1 MB

SEC Filing Details

Document Details

Form
4
Filing Date
Aug 13, 2018
Document Date
Aug 3, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Harvard Bioscience, Inc.
Issuer
HARVARD BIOSCIENCE INC
Filer
Gagnon Robert E

Filing Formats

View HTML
Download PDF
Download DOC

Shareholder Tools

Printed Materials
Email Alerts
Downloads
RSS
Print
Share
  • Facebook
  • Google
  • LinkedIn
  • Twitter
  • RSS
  • © 2019 Harvard Bioscience, Inc.
  • All rights reserved
  • Privacy Policy.
  • Terms & Conditions
  • Site Map